Nektar Therapeutics | NKTR - بدهی های جاری

قیمت سهام
77.50
تغییر روزانه
-0.35 -0.45%
ماهیانه
5.69%
سالیانه
736.44%
Q2 پیش بینی
75.38




بدهی های جاری تغییر دادن تاریخ
Agios Pharmaceuticals USD 82.21M 7.45M 2025-12
ALKERMES USD 543.44M 69.08M 2025-12
Alterity Therapeutics Limited AUD 1.73M 2.77M 2025-12
Amgen USD 25.49B 3.7B 2025-12
Baxter International USD 2.97B 805M 2025-12
BioCryst Pharmaceuticals USD 196.07M 5.83M 2025-12
Biogen USD 3.35B 59.4M 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Cara Therapeutics USD 11.04M 362K 2025-09
Cipla INR 62.97B 8.13B 2025-09
Dr.Reddys Laboratories INR 158.31B 7.38B 2025-12
Eisai JPY 387.67B 9.42B 2025-12
Eli Lilly USD 35.23B 4.91B 2025-12
Esperion Therapeutics USD 300.81M 58.22M 2025-12
Exelixis USD 405.64M 31.86M 2025-12
Gilead Sciences USD 11.81B 485M 2025-12
GlaxoSmithKline GBP 21.39B 57M 2025-12
Grifols EUR 2.37B 156.97M 2025-12
Halozyme Therapeutics USD 177.09M 660.14M 2025-12
Incyte USD 1.52B 176.44M 2025-12
Ionis Pharmaceuticals USD 783M 120.46M 2025-12
Ironwood Pharmaceuticals USD 242.5M 9.98M 2025-09
Karyopharm Therapeutics USD 92.06M 4.9M 2025-12
MacroGenics USD 43.11M 1.36M 2025-12
Merck USD 28.63B 2.59B 2025-09
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Neurocrine Biosciences USD 743.4M 105.4M 2025-12
Novartis USD 27.28B 4.72B 2025-12
Pfizer USD 36.6B 1.13B 2025-09
Roche Holding CHF 28B 421M 2025-12
Sarepta Therapeutics USD 1.1B 173.86M 2025-12
Takeda JPY 2.61T 470.53B 2025-12
Teva Pharmaceutical Industries USD 13.46B 1.96B 2025-12
Xencor USD 95.91M 9.42M 2025-12